Antineoplastic Combined Chemotherapy ProtocolsTransplantation, AutologousCombined Modality TherapyPeripheral Blood Stem Cell TransplantationAntineoplastic AgentsCyclophosphamideTreatment OutcomeChemotherapy, AdjuvantHematopoietic Stem Cell TransplantationRadiation InjuriesRadiation DosageRadiation, IonizingDose-Response Relationship, RadiationCisplatinDoxorubicinRadiotherapyRadiotherapy DosageRadiation ToleranceNeoplasmsSalvage TherapyLymphoma, Non-HodgkinCell Line, TumorDose-Response Relationship, DrugRadiationDrug Screening Assays, AntitumorBreast NeoplasmsRadiotherapy, ConformalRadiotherapy, AdjuvantRadiation OncologyDrug Resistance, NeoplasmEtoposideRadiotherapy, Intensity-ModulatedRadiation ProtectionNeoplasm StagingDose FractionationRadiation MonitoringDisease-Free SurvivalSurvival AnalysisAntineoplastic Agents, PhytogenicLung NeoplasmsPaclitaxelNeoplasm Recurrence, LocalTime FactorsApoptosisSurvival RatePrognosisAntibiotics, AntineoplasticNeoadjuvant TherapyDrug Administration ScheduleRadiotherapy Planning, Computer-AssistedBrain NeoplasmsRadiation PneumonitisBrachytherapyCell SurvivalFollow-Up StudiesRadiation-Sensitizing AgentsVinblastineRadiometryAdenocarcinomaMethotrexateCarboplatinAntimetabolites, AntineoplasticBleomycinNeoplasms, Radiation-InducedCamptothecinAntineoplastic Agents, AlkylatingHead and Neck NeoplasmsGamma RaysDrug Delivery SystemsXenograft Model Antitumor AssaysCranial IrradiationOrganoplatinum CompoundsTumor Cells, CulturedMice, NudeRadiation Injuries, ExperimentalCarcinoma, Squamous CellRadiosurgeryTaxoidsCarcinoma, Non-Small-Cell LungDeoxycytidineClinical Trials as TopicProspective StudiesDNA DamageDacarbazineDrug CarriersNeoplasm MetastasisCell ProliferationTomography, X-Ray ComputedCosmic RadiationChemoradiotherapyMitomycinRetrospective StudiesRadiotherapy, Computer-AssistedProstatic NeoplasmsOvarian NeoplasmsRadiotherapy, High-EnergyHodgkin DiseaseP-GlycoproteinDrug Resistance, MultipleAnthracyclines